Zachary Melchiode

Methodist Hospital

Papers

2

Total Citations

4

H-Index

1

About

Zachary Melchiode is a surgical outcomes researcher whose work focuses on the comparative effectiveness of minimally invasive techniques in urologic oncology. His primary research areas include robotic-assisted surgery for bladder and kidney cancers, with a particular emphasis on perioperative morbidity and mortality. Melchiode’s major contributions involve leveraging large national databases—specifically the National Surgical Quality Improvement Program (NSQIP) procedure-targeted datasets—to provide real-world evidence comparing open, laparoscopic, and robotic approaches. His most cited paper (3 citations, 2024) examines contemporary morbidity and mortality of open versus robotic cystectomy for bladder cancer, offering critical insights into surgical decision-making. A subsequent 2025 study compares robotic versus laparoscopic radical nephrectomy for renal cell carcinoma, further establishing his expertise in evidence-based surgical practice. While his citation counts are still growing, Melchiode’s work is notable for its methodological rigor and direct clinical relevance, helping surgeons and patients weigh the risks and benefits of advanced surgical technologies. His research contributes to the ongoing debate about the true value of robotic surgery in oncology.

Research Focus

Key Achievements

1
H-Index
2
Papers
4
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Contemporary morbidity and mortality of open versus robotic cystectomy for bladder cancer: An analysis of the National Surgical Quality Improvement Program (NSQIP) procedure targeted cystectomy database
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Methodist Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago